243 related articles for article (PubMed ID: 27594563)
1. New peptides players in metabolic disorders.
Mierzwicka A; Bolanowski M
Postepy Hig Med Dosw (Online); 2016 Aug; 70(0):881-6. PubMed ID: 27594563
[TBL] [Abstract][Full Text] [Related]
2. Three new players in energy regulation: preptin, adropin and irisin.
Aydin S
Peptides; 2014 Jun; 56():94-110. PubMed ID: 24721335
[TBL] [Abstract][Full Text] [Related]
3. Progranulin, a New Adipokine at the Crossroads of Metabolic Syndrome, Diabetes, Dyslipidemia and Hypertension.
Korolczuk A; Bełtowski J
Curr Pharm Des; 2017; 23(10):1533-1539. PubMed ID: 28120721
[TBL] [Abstract][Full Text] [Related]
4. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
Kravchun P; Kadykova O; Gabisoniia T
Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
[TBL] [Abstract][Full Text] [Related]
5. Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo.
Cornish J; Callon KE; Bava U; Watson M; Xu X; Lin JM; Chan VA; Grey AB; Naot D; Buchanan CM; Cooper GJ; Reid IR
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E117-22. PubMed ID: 16912056
[TBL] [Abstract][Full Text] [Related]
6. Organokines in disease.
Chung HS; Choi KM
Adv Clin Chem; 2020; 94():261-321. PubMed ID: 31952573
[TBL] [Abstract][Full Text] [Related]
7. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.
Jung UJ; Choi MS
Int J Mol Sci; 2014 Apr; 15(4):6184-223. PubMed ID: 24733068
[TBL] [Abstract][Full Text] [Related]
8. Preptin in women with polycystic ovary syndrome.
Mierzwicka A; Kuliczkowska-Plaksej J; Kolačkov K; Bolanowski M
Gynecol Endocrinol; 2018 Jun; 34(6):470-475. PubMed ID: 29374985
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovary syndrome, adipose tissue and metabolic syndrome.
Delitala AP; Capobianco G; Delitala G; Cherchi PL; Dessole S
Arch Gynecol Obstet; 2017 Sep; 296(3):405-419. PubMed ID: 28643028
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
11. Osteocalcin, energy and glucose metabolism.
Zanatta LC; Boguszewski CL; Borba VZ; Kulak CA
Arq Bras Endocrinol Metabol; 2014 Jul; 58(5):444-51. PubMed ID: 25166034
[TBL] [Abstract][Full Text] [Related]
12. Preptin: A New Bone Metabolic Parameter?
Ungureanu MC; Bilha SC; Hogas M; Velicescu C; Leustean L; Teodoriu LC; Preda C
Metabolites; 2023 Sep; 13(9):. PubMed ID: 37755271
[TBL] [Abstract][Full Text] [Related]
13. The role of insulin and selected adipocytokines in patients with polycystic ovary syndrome (PCOS) - a literature review.
Ozegowska KE; Pawelczyk LA
Ginekol Pol; 2015 Apr; 86(4):300-4. PubMed ID: 26117990
[TBL] [Abstract][Full Text] [Related]
14. [The role of peroxisome proliferator-activated receptors γ (PPARγ) in obesity and insulin resistance].
Chmielewska-Kassassir M; Woźniak LA; Ogrodniczek P; Wójcik M
Postepy Hig Med Dosw (Online); 2013 Dec; 67():1283-99. PubMed ID: 24379269
[TBL] [Abstract][Full Text] [Related]
15. Intricacies of the endothelin system in human obesity: role in the development of complications and potential as a therapeutic target.
Schinzari F; Cardillo C
Can J Physiol Pharmacol; 2020 Sep; 98(9):563-569. PubMed ID: 32808824
[TBL] [Abstract][Full Text] [Related]
16. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and Hepatokines.
Oh KJ; Lee DS; Kim WK; Han BS; Lee SC; Bae KH
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28025491
[TBL] [Abstract][Full Text] [Related]
18. Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism.
Rodríguez A; Ezquerro S; Méndez-Giménez L; Becerril S; Frühbeck G
Am J Physiol Endocrinol Metab; 2015 Oct; 309(8):E691-714. PubMed ID: 26330344
[TBL] [Abstract][Full Text] [Related]
19. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
Lewis GF; Carpentier A; Adeli K; Giacca A
Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
[TBL] [Abstract][Full Text] [Related]
20. Novel adipokines: their potential role in the pathogenesis of obesity and metabolic disorders.
Korek E; Krauss H
Postepy Hig Med Dosw (Online); 2015 Jan; 69(0):799-810. PubMed ID: 28148886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
